GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cryomass Technologies Inc (OTCPK:CRYM) » Definitions » Price-to-Operating-Cash-Flow

Cryomass Technologies (Cryomass Technologies) Price-to-Operating-Cash-Flow : (As of May. 29, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Cryomass Technologies Price-to-Operating-Cash-Flow?

As of today (2024-05-29), Cryomass Technologies's share price is $0.0501. Cryomass Technologies's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.02. Hence, Cryomass Technologies's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Cryomass Technologies's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 12 years, Cryomass Technologies's highest Price-to-Operating-Cash-Flow Ratio was 580.00. The lowest was 0.00. And the median was 580.00.

CRYM's Price-to-Operating-Cash-Flow is not ranked *
in the Drug Manufacturers industry.
Industry Median: 16.77
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Cryomass Technologies's Cash Flow from Operations per share for the three months ended in Sep. 2023 was $-0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.02.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -6.30% per year.

During the past 12 years, Cryomass Technologies's highest 3-Year average Operating Cash Flow per Share Growth Rate was -6.30% per year. The lowest was -72.60% per year. And the median was -51.80% per year.


Cryomass Technologies Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Cryomass Technologies's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryomass Technologies Price-to-Operating-Cash-Flow Chart

Cryomass Technologies Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Cryomass Technologies Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Cryomass Technologies's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Cryomass Technologies's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cryomass Technologies's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cryomass Technologies's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Cryomass Technologies's Price-to-Operating-Cash-Flow falls into.



Cryomass Technologies Price-to-Operating-Cash-Flow Calculation

Cryomass Technologies's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=0.0501/-0.021
=

Cryomass Technologies's Share Price of today is $0.0501.
Cryomass Technologies's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.02.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Cryomass Technologies Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Cryomass Technologies's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Cryomass Technologies (Cryomass Technologies) Business Description

Traded in Other Exchanges
N/A
Address
1001 Bannock Street, Suite 612, Denver, CO, USA, 80204
Cryomass Technologies Inc designs, manufactures, and licenses field-mobile equipment for the handling of harvested cannabis, hemp, and other high-value plant material. The company owns patented technology that utilizes liquid nitrogen to fully separate, collect and protect the high-value compounds from the harvested plant. The company's offerings include refinement systems and monitoring and control systems.
Executives
Philip Blair Mullin officer: Chief Financial Officer 3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Christian Noel director, officer: Chief Executive Officer 3531 SOUTH LOGAN ST. SUITE D-357, ENGLEWOOD CO 80113
Patricia Izabel Kovacevic officer: GC, Corp Secy, and Head of EA 3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Delon Hannes Human director 3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Mark Radke director 3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Mario Gobbo director 3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113